VIYASH SCIENTIFIC LIMITED — Call Transcript 2025

May 13, 2025

==> picture [153 x 43] intentionally omitted <==

Proven Ability In Life Sciences

May 13, 2025

To,

BSE Limited National Stock Exchange of India Limited Corporate Relationship Department Listing Department Phiroze Jeejeebhoy Towers, Exchange Plaza, Bandra-Kurla Complex, Dalal Street, Fort, Bandra (East), Mumbai – 400 001 Mumbai – 400 051 Scrip code: 512529 Symbol: SEQUENT

Subject: Intimation of Conference call

Dear Sir/ Madam,

Pursuant to Regulation 30 read with Part A of Schedule III of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, kindly note that the Company has scheduled a conference call with the Analysts/Investors on Wednesday, May 21, 2025, at 9.00 a.m. (I.S.T.) to discuss its Q4FY25 financial results. The Conference call details are enclosed herewith.

The above details are also available on the website of the Company in the Investors Section at: www.sequent.in

You are requested to take the same on record.

Yours faithfully,

For Sequent Scientific Limited

Vora Yoshita Digitally signed by Vora Yoshita Susmit DN: c=IN, o=Personal, title=8303, pseudonym=133542728235831333zlajGRdyX6Bd33, 2.5.4.20=d020b6fdf92ebf460444c17a43852012a8944c9c Susmit 186ec050fc273289b70ff6ad, postalCode=390007, st=Gujarat, serialNumber=f772b1940c11eaa0982689cb57b6dd9f83b02dcf1f02d876a6e91c46738fac2b, cn=Vora Yoshita Susmit Date: 2025.05.13 12:36:48 +05'30'

Yoshita Vora Company Secretary & Compliance Officer Encl.: A/a

SeQuent Scientific Limited

Registered Office: 301, 3[rd] Floor, Dosti Pinnacle, Plot No. E7, Road No. 22, Wagle Industrial Estate, Thane (W), Mumbai - 400604, Maharashtra, India Tel No.: +91-22-4111-4777 I CIN: L99999MH1985PLC036685 Website : http://www.sequent.in I Email Id : investorrelations@sequent.in

==> picture [421 x 506] intentionally omitted <==

==> picture [161 x 40] intentionally omitted <==

SeQuent Q4FY25

Earnings Conference Call 21[st] May 2025, 9:00AM

Speakers

Mr. Rajaram Narayanan, MD & CEO, Sequent Scientific Dr. Hari Babu Bodepudi, WTD & CEO, Viyash Lifesciences Mr. Saurav Bhala, Chief Financial Officer, Sequent Scientific Mr. Ramakant Singani, Chief Financial Officer, Viyash Lifesciences

Dial in For SeQuent Q4FY25 Conference call, Details: 21st May 2025, Time: 9:00 AM +91 22 6280 1263 Universal +91 22 7115 8213 Access DiamondPass (for early Click here registration)